| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 285-70-1 | 6-Oxa-3-thiabicyclo[3.1.0]hexane(8CI,9CI); Thiophene,3,4-epoxytetrahydro- |  | C4H6OS | 詳情 | 供應(yīng)商 | |
| 85-65-4 | 6-Isoquinolinol,1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-7-methoxy-2-methyl- (9CI); 6-Isoquinolinol,1,2,3,4-tetrahydro-7-methoxy-2-methyl-1-veratryl- (7CI,8CI); Pseudolaudanine |  | C20H25NO4 | 詳情 | 供應(yīng)商 | |
| 641-38-3 | 6H-Dibenzo[b,d]pyran-6-one,3,7,9-trihydroxy-1-methyl-; Alternariol(6CI,7CI); NSC 638263 |  | C14H10O5 | 詳情 | 供應(yīng)商 | |
| 20287-37-0 | 6-Quinazolinesulfonamide,7-chloro-1,2,3,4-tetrahydro-4-oxo-2-phenyl-; 2-Phenyl-6-sulfamoyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone; 2-Phenyl-7-chloro-6-sulfamoyl-1,2,3,4-tetrahydro-4-quinazolinone; Fenquizone; Idrolone; MG 13054 |  | C14H12ClN3O3S | 詳情 | 供應(yīng)商 | |
| 6318-01-0 | 6-Quinazolinecarboxamide,2,4-dichloro-N-(4-chlorophenyl)-5,6,7,8-tetrahydro-; 6-Quinazolinecarboxanilide,2,4,4'-trichloro-5,6,7,8-tetrahydro- (6CI); NSC 27376 |  | C15H12Cl3N3O | 詳情 | 供應(yīng)商 | |
| 113615-65-9 | 6,9-Diazaspiro[4.5]dec-8-en-10-one,8-amino-6-phenyl- |  | C14H17N3O | 詳情 | 供應(yīng)商 | |
| 23013-84-5 | 6H-Benzofuro[3,2-c][1]benzopyran-6-one,3,9-dihydroxy-1-methoxy-2-(3-methyl-2-buten-1-yl)-; 6H-Benzofuro[3,2-c][1]benzopyran-6-one,3,9-dihydroxy-1-methoxy-2-(3-methyl-2-butenyl)- (9CI); Glycyrol; Neoglycyrol |  | C21H18O6 | 詳情 | 供應(yīng)商 | |
| 148504-32-9 | 6,8,10-Eicosatrienoicacid, 5,12-dihydroxy-12-methyl-, [R-[R*,R*-(E,Z,E)]]- (9CI); 12-methylleukotriene B3 |  | C21H36O4 | 詳情 | 供應(yīng)商 | |
| 78859-36-6 | 6H-2,5,6a,7-Tetraazafluoranthen-3-amine,1-methyl-; Orn-P 1 |  | C13H11N5 | 詳情 | 供應(yīng)商 | |
| 153901-49-6 | 6H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepin-5-amine,N,N-dimethyl-6-phenyl- |  | C18H17N5 | 詳情 | 供應(yīng)商 | |
| 78278-06-5 | 6-Quinazolinesulfonicacid, 1,3-dichloro-1,2,3,4-tetrahydro-2,4-dioxo-, sodium salt (1:1); 6-Quinazolinesulfonicacid, 1,3-dichloro-1,2,3,4-tetrahydro-2,4-dioxo-, sodium salt (9CI) |  | C8H3Cl2N2NaO5S | 詳情 | 供應(yīng)商 | |
| 5845-36-3 | 6H-Purin-6-one,1,9-dihydro-9-(3-methoxypropyl)-; Hypoxanthine,9-(3-methoxypropyl)- (7CI,8CI) |  | C9H12N4O2 | 詳情 | 供應(yīng)商 | |
| 117011-51-5 | 6H-Purin-6-one,2-amino-1,9-dihydro-9-(4-hydroxy-1,2-butadien-1-yl)-; 6H-Purin-6-one,2-amino-1,9-dihydro-9-(4-hydroxy-1,2-butadienyl)- (9CI); 6H-Purin-6-one, 2-amino-1,9-dihydro-9-(4-hydroxy-1,2-butadienyl)-,(?à)-; Guanallene |  | C9H9N5O2 | 詳情 | 供應(yīng)商 | |
| 158999-13-4 | 6H-Furo[3,2-e]indol-4-ol,8-(chloromethyl)-7,8-dihydro-1-methyl-, (R)- (9CI); 1,2-dihydro-1-(chloromethyl)-5-hydroxy-8-methyl-3H-furano(3,2-e)indole |  | C12H12ClNO2 | 詳情 | 供應(yīng)商 | |
| 157230-10-9 | 6,3-p-Dihydroxypaclitaxel; 6,3’-p-dihydroxypaclitaxel |  | C47H51NO16 | 詳情 | 供應(yīng)商 | |
| 28848-19-3 | 6,9-Dithia-2,12-disilatetradecane; Silane,ethyl[2-[[2-[[3-(methylsilyl)propyl]thio]ethyl]thio]ethyl]- |  | C10H26S2Si2 | 詳情 | 供應(yīng)商 | |
| 34827-33-3 | 6,7-Isoquinolinediol,1,2,3,4-tetrahydro-; 1,2,3,4-Tetrahydroisoquinoline-6,7-diol; 6,7-Dihydroxy-1,2,3,4-tetrahydroisoquinoline; 6,7-Dihydroxytetrahydroisoquinoline; Norsalsolinol; Tetrahydro-6,7-isoquinolinediol |  | C9H11NO2 | 詳情 | 供應(yīng)商 | |
| 51165-07-2 | 6-11-SubstanceP; SubstanceP,1-de-L-arginine-2-de-L-proline-3-de-L-lysine-4-de-L-proline-5-de-L-glutamine-; 38: PN: WO0146415 SEQID: 38 claimed protein; 40-45-Tachykinin ATT (Atypicaltachykinin) (human); Hexa(6-11)substance P; Substance P6-11 |  | C36H52N8O7S | 詳情 | 供應(yīng)商 | |
| 21333-26-6 | 6H-Purin-6-one,2-amino-9-(2-chlorophenyl)-1,9-dihydro-; Guanine,9-(o-chlorophenyl)- (8CI); NSC 210390 |  | C11H8ClN5O | 詳情 | 供應(yīng)商 | |
| 30076-55-2 | 6-Benzothiazolecarbamicacid, 2-piperidino-, ethyl ester (8CI); NSC 278793 |  | C15H19N3O2S | 詳情 | 供應(yīng)商 | |